Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Non-Current Assets (2019 - 2025)

Historic Non-Current Assets for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $5.1 million.

  • Volitionrx's Non-Current Assets fell 1296.93% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year decrease of 1071.89%. This contributed to the annual value of $5.3 million for FY2024, which is 1236.28% down from last year.
  • Volitionrx's Non-Current Assets amounted to $5.1 million in Q3 2025, which was down 1296.93% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, Volitionrx's Non-Current Assets registered a high of $6.1 million during Q4 2022, and its lowest value of $5.1 million during Q3 2025.
  • Moreover, its 5-year median value for Non-Current Assets was $5.7 million (2022), whereas its average is $5.7 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 1109.33% in 2022, then tumbled by 1296.93% in 2025.
  • Over the past 5 years, Volitionrx's Non-Current Assets (Quarter) stood at $5.5 million in 2021, then rose by 11.09% to $6.1 million in 2022, then dropped by 0.43% to $6.1 million in 2023, then fell by 12.36% to $5.3 million in 2024, then dropped by 4.23% to $5.1 million in 2025.
  • Its Non-Current Assets was $5.1 million in Q3 2025, compared to $5.4 million in Q2 2025 and $5.2 million in Q1 2025.